|
Husson, Herve; Carideo, Elizabeth G; Neuberg, Donna et al. (2002) Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 99:282-9
|
|
Husson, H; Lugli, S M; Ghia, P et al. (2000) Functional effects of TNF and lymphotoxin alpha1beta2 on FDC-like cells. Cell Immunol 203:134-43
|
|
Grossbard, M L; Multani, P S; Freedman, A S et al. (1999) A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma. Clin Cancer Res 5:2392-8
|
|
Grossbard, M L; Fidias, P; Kinsella, J et al. (1998) Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma. Br J Haematol 102:509-15
|
|
Ghia, P; Boussiotis, V A; Schultze, J L et al. (1998) Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 91:244-51
|
|
Astier, A; Manie, S N; Law, S F et al. (1997) Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells. Leuk Lymphoma 28:65-72
|
|
Astier, A; Avraham, H; Manie, S N et al. (1997) The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem 272:228-32
|
|
Astier, A; Manie, S N; Avraham, H et al. (1997) The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. J Biol Chem 272:19719-24
|
|
Manie, S N; Beck, A R; Astier, A et al. (1997) Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 272:4230-6
|
|
Manie, S N; Sattler, M; Astier, A et al. (1997) Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation. Exp Hematol 25:45-50
|
Showing the most recent 10 out of 29 publications
